Steven B. Ketchum, Chief Scientific Officer at AMARIN CORP PLC\UK (AMRN), sold 34,131 shares at $0.79 ($27K) on 2023-12-12, disclosed to the SEC on 2023-12-14.
Scheduled sale ($27k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMRN | SELL | 2019-05-02 | $356K | — | Filing → |
| AMRN | SELL | 2019-04-01 | $381K | — | Filing → |
| AMRN | SELL | 2019-03-01 | $2.4M | — | Filing → |